FDA Adverse Event Injury Summary report: N

ENTERPRISE VASCULAR RECONSTRUCTION DEVICE AND DELIVERY SYSTEM

MDR report key: 1220549 · Received November 4, 2008

Report

Report Number
1058196-2008-00263
Event Type
Injury
Date Received
November 4, 2008
Report Date
October 9, 2008
Manufacturer
CORDIS NEUROVASCULAR, INC.
Product Code
NJE
PMA / PMN Number
HDEH60001
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

NOTE: LAKE REGION LOT NUMBER IS CORDIS LOT NUMBER. PER LAKE REGION REPORT: CORDIS NEUROVASCULAR REPORTED NO PRODUCT IS EXPECTED TO BE RETURNED TO LAKE REGION MEDICAL FOR EVAL; HOWEVER, A COPY OF THE INVESTIGATION REQUESTED INCLUDING LOT TRACEABILITY WAS PROVIDED. WITHOUT THE RETURN OF THE ACTUAL DEVICE IN QUESTION FOR EVAL, LAKE REGION MEDICAL IS UNABLE TO DETERMINE THE EXACT CAUSE FOR THIS INCIDENT. LAKE REGION MEDICAL DID REVIEW THE DEVICE HISTORY RECORDS RELATIVE TO THE MANUFACTURING, INSPECTING AND PACKAGING. THIS PACKAGING LOT CONTAINED 24 UNITS, WHICH WERE SHIPPED FROM LAKE REGION MEDICAL ON 12/21/07. THE HISTORY RECORDS INDICATE THIS PRODUCT WAS FINAL INSPECTION TESTED AT LAKE REGION MEDICAL AND WAS DETERMINED TO BE ACCEPTABLE. ADDITIONAL INFORMATION WILL BE SUBMITTED WITHIN 30 DAYS UPON RECEIPT.

Description of Event or Problem · 1

THE PT UNDERWENT SUCCESSFUL DEPLOYMENT OF THE CORDIS ENTERPRISE STENT ACROSS A RIGHT SUPRACLINOID INTERNAL CAROTID ARTERY ANEURYSM. AFTER PLACEMENT, NORMAL ANTEGRADE FILLING WITHIN THE RIGHT OPHTHALMIC ARTERY WAS NOTED. THE PT WAS SEEN ONE MONTH LATER AND REPORTED NO NEUROLOGICAL SYMPTOMS. SHE WAS SCHEDULED FIVE MONTHS LATER FOR EMBOLIZATION OF THE ANEURYSM THROUGH THE STENT. CEREBRAL ANGIOGRAPHY WAS PERFORMED PRIOR TO EMBOLIZATION DEMONSTRATED RIGHT OPTHALMIC OPACIFICATION IN AN ANTEGRADE FASHION FILLING FROM THE EXTERNAL CAROTID ARTERY CIRCULATION. THIS FILLING SUGGESTS ASYMPTOMATIC OCCLUSION OF THE CIRCULATION OF THE OPHTHALMIC ARTERY FROM THE INTERNAL CAROTID ARTERY THAT TOOK PLACE SOMETIME AFTER THE PLACEMENT OF THE STENT. SHE REMAINED NEUROLOGICALLY INTACT WITH NO REPORTED VISUAL CHANGES POST EMBOLIZATION. PATIENT'S OPHTHALMIC ARTERY WAS TINY, BUT HAD DUAL SUPPLY IDENTIFIED ON PRE ANGIO FROM EXTERNAL CAROTID ARTERY. KNOWN RISK OF CLOSED CELL DESIGN STENTING, ESPECIALLY AROUND CURVED SMALL ARTERIES. THIS (PROTECTIVE) STENT WAS DEEMED PRE-OP SAFER THAN CONVENTIONAL NEUROLOSURGICAL APPROACH. VISION WITHOUT CHANGE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENTERPRISE VASCULAR RECONSTRUCTION DEVICE AND DELIVERY SYSTEM CNV ENTERPRISE SES (NJE) NJE CORDIS NEUROVASCULAR, INC. NA 13301935

Patients

Seq Age Sex Outcome Treatment
1 48 YR